Qualitative and Quantitative NAD(+) Metabolomics Lead to Discovery of Multiple [PMID: 31611893] Laboratory literature summary: Qualitative and Quantitative NAD(+) Metabolomics Lead to Discovery of Multiple Functional Nicotinate N-Glycosyltransferase in Arabidopsis
Developed by the same company (Eli Lilly), it was first approved in 2022 for type 2 diabetes but it quickly turned heads when patients on it started losing significant weight
But for now, this study suggests something hopeful: medications originally designed for blood sugar and weight may be helping the brain and reducing the chances of another stroke
The Exposome is the cumulative impact of our exposures, which is hard to measure
Trying to request time off of work, using hours of Paid Time Off (PTO) just for a 30-minute appointment
As with COVID, healthcare providers responded to the situation at hand and learned the nuances of the disease and modified treatment protocols over time as more information became available